Amarin Corp Plc (AMRN)

[sstyles]

Hikma CEO. See his bio and post work experience below. He used to be President of the generics business of Teva.

https://www.hikma.com/media/1408/sigurdur-olafsson-appoint-chief-executive-officer-of-hikma.pdf

Further background on Sigurdur OlafssonMr Olafsson has significant international experience in the pharmaceutical industry. He was most recently President and Chief Executive Officer of the Gl obal Generic Medicines Group of Teva Pharmaceuticals, a position he held from 2014 to 2016. From 2012 to 2014, he was President of Actavis. Prior to this, he wasExecutive Vice President, Global Generics, at Actavis plc (Watson) from 2010 to 2012; and CEO of theActavis Group from 2008 to 2010. From 2003 to 2008, he held positions of increasing responsibility withinthe Actavis Group, including Deputy CEO, Vice President of Corporate Development and CEO of ActavisInc. US. From 1998 to 2003, he held positions of increasing responsibility with Pfizer’s Global R&Dorganization in the UK and US. From 1994 to 1998, he served as Head of Drug Development for OmegaFarma in Iceland. He currently serves as a member of the board of directors for Elucida Oncology andPfenex Inc.